Zegerid OTC

Manufacturer: Bayer HealthCare LLC
Effective date: 2019-11-14
Label type: HUMAN OTC DRUG LABEL
Version: 12
Source: legacy-cache
Hydrated at: 2026-08-02 00:01:14

Label at a glance#

ProductZegerid OTC

Active ingredientOMEPRAZOLE, SODIUM BICARBONATE

Label structure10 sections

Dosage and administration

for adults 18 years of age and older this product is to be used once a day (every 24 hours), every day for 14 days it may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours 14-Day Course of Treatment swallow 1 capsule with a glass of water at least 1 hour before eating in the morning take every day for 14 days do not take more than 1 capsule a day do not chew or ...

Storage and handling

each capsule contains: sodium 303 mg read the directions, warnings and accompanying label information before use store at 20°-25°C (68°-77°F) tamper-evident: do not use if the blue band around the capsule is missing or broken. Do not use if foil inner seal imprinted with, "Sealed for your protection" is missing, open or broken. keep product out of high heat and humidity protect product from moisture

Contacts and useful links#

PhoneLabel contact1-888-493-4682

Websitewww.zegeridotc.com

www.ZegeridOTC.com

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredients (in each capsule)	Purpose
Omeprazole 20 mg	Acid reducer
Sodium Bicarbonate 1100 mg	Allows absorption of this omeprazole product

Use

INDICATIONS & USAGE SECTION

treats frequent heartburn (occurs 2 or more days a week)
not intended for immediate relief of heartburn, this drug may take 1 to 4 days for full effect.

Warnings

WARNINGS SECTION

Allergy alert

SPL UNCLASSIFIED SECTION

Do not use if you are allergic to omeprazole

OTC - DO NOT USE SECTION

Do not use if you have:

trouble or pain swallowing food
vomiting with blood
bloody or black stools

These may be signs of a serious condition. See your doctor.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

had heartburn over 3 months. This may be a sign of a more serious condition.
heartburn with lightheadedness, sweating or dizziness
chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
frequent chest pain
frequent wheezing, particularly with heartburn
unexplained weight loss
nausea or vomiting
stomach pain
a sodium-restricted diet

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking

warfarin, clopidogrel or cilostazol (blood-thinning medicines)
prescription antifungal or anti-yeast medicines
diazepam (anxiety medicine)
digoxin (heart medicine)
tacrolimus or mycophenolate mofetil (immune system medicines)
prescription antiretrovirals (medicines for HIV infection)
methotrexate (arthritis medicine)
any other prescription drugs. Sodium bicarbonate may interact with certain prescription drugs

Stop use and ask doctor if

OTC - STOP USE SECTION

your heartburn continues or worsens
you need to take this product for more than 14 days
you need to take more than 1 course of treatment every 4 months
you get diarrhea
you develop a rash or joint pain

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding , ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

for adults 18 years of age and older
this product is to be used once a day (every 24 hours), every day for 14 days
it may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours
- 14-Day Course of Treatment
  - swallow 1 capsule with a glass of water at least 1 hour before eating in the morning
  - take every day for 14 days
  - do not take more than 1 capsule a day
  - do not chew or crush the capsule
  - do not open capsule and sprinkle on food
  - do not use for more than 14 days unless directed by your doctor
- Repeated 14-Day Courses (if needed)
  - you may repeat a 14-day course every 4 months
  - do not take for more than 14 days or more often than every 4 months unless directed by a doctor
children under 18 years of age: ask a doctor

Heartburn in children may sometimes be caused by a serious condition.

Other information

STORAGE AND HANDLING SECTION

each capsule contains: sodium 303 mg
read the directions, warnings and accompanying label information before use
store at 20°-25°C (68°-77°F)
tamper-evident: do not use if the blue band around the capsule is missing or broken. Do not use if foil inner seal imprinted with, "Sealed for your protection" is missing, open or broken.
keep product out of high heat and humidity
protect product from moisture

Inactive ingredients

INACTIVE INGREDIENT SECTION

croscarmellose sodium, FD&C blue No. 1, gelatin, magnesium stearate, pharmaceutical ink, polysorbate 80, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

Questions or comments?

Call 1-888-4-ZEG-OTC (1-888-493-4682) between 9:00 AM and 5:00 PM Eastern Standard Time, Monday through Friday or visit www.ZegeridOTC.com

SPL UNCLASSIFIED SECTION

Dist by: Bayer HealthCare LLC, Whippany, NJ 07981
Product of Spain.

PRINCIPAL DISPLAY PANEL - 42 Capsule Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Treats Frequent Heartburn

Zegerid

OTC ^®

• Omeprazole 20 mg/Acid Reducer

• Sodium Bicarbonate 1100 mg/

Allows Absorption of this Omeprazole Product

42

CAPSULES

Three 14-Day Courses of Treatment

Carton 42 count

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
11523-7265-1	EA - Each	11523-7265	836013f9-2437-4e3d-a372-17bb43fb2a6d	1	2012-07-24
11523-7265-2	EA - Each	11523-7265	7ca5ee09-f083-4aa1-ae94-d19e1e1483ff	1	2012-07-24
11523-7265-3	EA - Each	11523-7265	d0c8b903-91b2-4f89-80c2-0b2d1cdc2bd3	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Omeprazole	ACTIVE INGREDIENT	KG60484QX9	7
Sodium Bicarbonate	ACTIVE INGREDIENT	8MDF5V39QO	7
Bicarbonate Ion	ACTIVE MOIETY	HN1ZRA3Q20	7
Omeprazole	ACTIVE MOIETY	KG60484QX9	7
croscarmellose sodium	INACTIVE INGREDIENT	M28OL1HH48	7
FD&C blue No. 1	INACTIVE INGREDIENT	H3R47K3TBD	7
gelatin	INACTIVE INGREDIENT	2G86QN327L	7
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	7
polysorbate 80	INACTIVE INGREDIENT	6OZP39ZG8H	7
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	7

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Zegerid OTC
Omeprazole and Sodium Bicarbonate
CROSCARMELLOSE SODIUM
FD&C BLUE NO. 1
GELATIN
MAGNESIUM STEARATE
POLYSORBATE 80
TITANIUM DIOXIDE
OMEPRAZOLE
SODIUM BICARBONATE
BICARBONATE ION

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
11523-7265	11523-7265-1, 11523-7265-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
FD&C BLUE NO. 1	H3R47K3TBD	IACT
GELATIN	2G86QN327L	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
OMEPRAZOLE	KG60484QX9	ACTIB
SODIUM BICARBONATE	8MDF5V39QO	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 260 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
gelatin	GELATIN	2G86QN327L	INJECTION / SUBCUTANEOUS	16 %w/v		Exact identifier — unii candidate 44 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	SOLUTION / RECTAL		315 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, COATED / ORAL		17 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	CAPSULE / ORAL	418.37 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SUSPENSION / INTRALESIONAL		4 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, COATED PELLETS / ORAL	4.4 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	FILM, SOLUBLE / BUCCAL		11 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	AEROSOL, FOAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 78 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	EMULSION / TOPICAL		34050 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	CAPSULE, LIQUID FILLED / ORAL	0.08 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	CAPSULE, COATED PELLETS / ORAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
gelatin	GELATIN	2G86QN327L	TABLET, FILM COATED / ORAL		57 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
gelatin	GELATIN	2G86QN327L	DROPS / NASAL	50 mg/1ml		Exact identifier — unii candidate 44 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	CREAM / TOPICAL		20 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	SOAP / TOPICAL	1 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	TABLET, FILM COATED / ORAL	0.16 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION / INTRASYNOVIAL	0.2 %w/v		Exact identifier — unii candidate 78 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	IMPLANT / INTRAVITREAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	RING / VAGINAL		2 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
croscarmellose sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	GRANULE / ORAL		150 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
croscarmellose sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET, COATED / ORAL		224 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SOLUTION / INTRAMUSCULAR	5 %w/v		Exact identifier — unii candidate 78 equally ranked IID candidates
croscarmellose sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	CAPSULE / ORAL		257 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / RECTAL	0.01 %w/v		Exact identifier — unii candidate 37 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	SOLUTION / AURICULAR (OTIC)	0.2 %w/w		Exact identifier — unii candidate 78 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	TABLET, ORALLY DISINTEGRATING / ORAL		1 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	CAPSULE, LIQUID FILLED / ORAL		24 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SUSPENSION / SOFT TISSUE		4 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION / INTRALESIONAL		4 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
croscarmellose sodium	CROSCARMELLOSE SODIUM	M28OL1HH48	TROCHE / ORAL		50 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
gelatin	GELATIN	2G86QN327L	PASTILLE / ORAL	143 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	SYSTEM / INTRAVITREAL	0.02 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	SOLUTION / ORAL	1.13 mg/15ml		Exact identifier — unii candidate 37 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SUSPENSION / INTRAVENOUS	0.5 %w/v		Exact identifier — unii candidate 78 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	PASTE / DENTAL	0.5 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
gelatin	GELATIN	2G86QN327L	INJECTION / INTRAVENOUS	20 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	CREAM / VAGINAL	0.4 %w/w		Exact identifier — unii candidate 78 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	PELLET / ORAL		24 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	SUSPENSION / ORAL		64 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	TABLET / SUBLINGUAL	0.08 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	MOUTHWASH / BUCCAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	SPRAY, METERED / NASAL	0.1 mg/1ml		Exact identifier — unii candidate 78 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE	1 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
gelatin	GELATIN	2G86QN327L	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 44 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	PASTE / ORAL		28 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	TABLET, FILM COATED / ORAL	24 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	53 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE / ORAL		127 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	PASTE, DENTIFRICE / DENTAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
FD&C blue No. 1	FD&C BLUE NO. 1	H3R47K3TBD	SUSPENSION / ORAL		1 mg	Exact identifier — unii candidate 37 equally ranked IID candidates
polysorbate 80	POLYSORBATE 80	6OZP39ZG8H	SUSPENSION / OPHTHALMIC		1 mg	Exact identifier — unii candidate 78 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022281-001	ZEGERID OTC	OMEPRAZOLE; SODIUM BICARBONATE	20MG;1.1GM	CAPSULE / ORAL		RLD, RS	2009-12-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022281-001	ZEGERID OTC	20MG;1.1GM	CAPSULE / ORAL	RLD, RS	2009-12-01	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
9751cf45-d729-5dae-e053-2a95a90a10eb			32bed6d8-8a9a-4fb0-a2f6-045892011ee4	2019-11-14	Warnings	Exact identifier spl id: 9751cf45-d729-5dae-e053-2a95a90a10eb spl set id: 32bed6d8-8a9a-4fb0-a2f6-045892011ee4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.